PRESS RELEASE: Govt of Guj signs MoU with IBS for Biotechnology venture
Intelligent Business Systems (IBS) signed a MoU with the Govt of Gujarat today to help them set up a Biotechnology Solutions Venture for the first time in India. Please find enclosed and attached the press release on the same. *Warm Regards,* *Aniket Thakur* *Adfactors PR Pvt. Ltd.* *Technology Communications Group* Raj Mahal, 4th Floor, 84, Veer Nariman Road , Churchgate, Mumbai 400020 tel: +91 22 2287 1361 fax: +91 22 2287 1365 mobile: +91 9892173022 *Knowledge-driven communications** *The information in this email is confidential and is intended solely for the addressee(s). Access to this email by anyone else is unauthorized. If you are not an intended recipient, you must not read, use or disseminate the information contained in this email *PRESS RELEASE** For Immediate Release* *IBS signs MoU with Government of Gujarat; partners with Gujarat State Biotechnology Mission * * * *IBS Centre for Bioinformatics to offer state-of-the-art* *research-based Biotechnology solutions towards modern medicine and therapy research * * * *Ahmedabad, 13th January 2007:* Intelligent Business Systems (IBS) and Government of Gujarat have signed a Memorandum of Understanding (MoU) today to partner in *Gujarat State Biotechnology Mission*. Gujarat is the first state in India to set up a Biotechnology Solutions Venture which will be aimed at Research Outsourcing. As part of the MoU, Intelligent Business Systems Centre for Bioinformatics (CfB) along with Shanku's Group will be providing the Bioinformatics & Biotechnology research based solutions respectively. IBS will deal with computer-aided drug discovery, drug interaction and bio-analysis. Also, Shanku's group will be investing Rs. 40 crore for the venture. Speaking on the occasion, Dr. Kaustubh Chokshi, CEO and co-Founder, IBS, said, "Gujarat with its very strong Pharma, Healthcare and Agriculture sectors offers an ideal platform to venture into the emerging Biotechnology industry. IBS with its strong academic roots and research based approach to providing innovative solutions, is privileged to be part of this initiative to tap the growing opportunity that Biotechnology offers." He added, "At IBS we pioneer the use of novel and developmental bioinformatics research. IBS will offer cutting edge solutions to facilitate the goals of modern medicine and therapy research." Intelligent Business Systems' CfB specialises in research and data analysis, which can be extended to provide an invaluable analytical insight into biological data and utilities to aid the scientific and commercial community in the understanding of genomic and proteomic data. CfB will collaborate with academia on problems of relevance to improve medication and healthcare delivery. The mathematical approach has numerous cutting-edge applications in modern medicine and therapy development. These include: · Individuals responding adversely to one or more drugs. · Predicting disease and treatment outcomes. · Improved economic and practical efficiencies in healthcare delivery, thus better targeting high cost treatment to those patients most likely to benefit from it. · Computationally complete genome sequence analysis and comparative genomics. · Development of intelligent systems for genome. · Protein interaction maps using gene fusion events. · Pattern discovery. · Evolution of the transcriptional machinery. · Development of standards for genome sequence annotation. · Document clustering and information extraction from biological text. · Precocious diagnosis of life-threatening disease. *About Intelligent Business Systems** ( www.intelligentsystems.biz)* *Intelligent Business Systems Ltd. * (IBS) is a futuristic and ultramodern company that provides innovative *AI Enterprise Solutions* and analytic applications for business, incorporating cutting-edge Artificial Intelligence (AI) technologies. Founded in the UK and recently expanded into India, the foundations of IBS are firmly embedded in academic research, and the company continues to have a strong R&D focus in everything it does. The core competence of IBS lies in *Artificial Intelligence*, with a sharp focus in applying the latest AI models to intelligent business solutions customised to specific client needs. IBS software utilises historical data from the organisation's databases, coupled with expert opinion and robust analytics, to ensure real-time execution of the organisational decision strategy and facilitation of a high degree of reliable decision automation. * * * * *For further Information please contact: * * * *Sandeep Viswanathan* *sandeep.viswanathan@adfactorspr.com * *Adfactors Public Relations* *+91 9967050959 * * * *Jennifer Disawala * *jennifer.disawala@intelligentsystems.biz * *Intelligent Business Systems* *+91 (22) 66126000*